Caribou gets FDA fast track for allogeneic CAR-T

Caribou gets FDA fast track for allogeneic CAR-T

Submitted by admin on April 11, 2023 - 10:02am
Source: 
Biopharma Reporter
News Tags: 
Caribou Biosciences
FDA
Multiple Myeloma
CAR-T
CB-011
Headline: 
Caribou gets FDA fast track for allogeneic CAR-T
snippet: 

The clinical stage company announces that its potential treatment for relapsed or refractory multiple myeloma receives nod for speedier review by the FDA.

Do Not Allow Advertisers to Use My Personal information